Marlana M. Orloff, Justin C. Moser, Alexander Shoushtari, Allison Betof, Diwakar Davar, Sunandana Chandra, Alexandra Ikeguchi, April K.S. Salama, Ryan J. Sullivan, Shaheer Khan, Sapna Pradyuman Patel, Anthony M. Joshua, Jessica Cecile Hassel, Mayowa Agbaje-Williams, Mark Navarro, Rahul Marpadga, Giuseppe Gullo, Joseph J. Sacco. "A randomized, phase 2/3 clinical trial investigating RP2 plus nivolumab vs ipilimumab plus nivolumab in immune checkpoint inhibitor–naïve patients with metastatic uveal melanoma.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.tps9598